BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Infographics: Dynamic digital data analysis
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, January 2, 2025
See today's BioWorld
Home
» Other news to note for Sept. 8, 2021
X
Upgrade your daily dose of biopharma and medtech news
Subscribe to BioWorld™ news services
See subscription options
To read the full article
sign up for free
or
sign in
.
Other news to note for Sept. 8, 2021
Sep. 8, 2021
No Comments
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Biocorrx, Bio-Thera, BMS, Boehringer, Bolt, Catabasis, CDR-Life, Cyrus, Design, Eirion, Engrail, Exscientia, Gain, Ginkgo, HTL, Huadong, Immunicum, Lexia, Moderna, National Resilience, Neurocrine, Northstar, Novaremed, Novartis, NTC, Point, Rain, Recro, Redhill, Satellos, Selecta, Stada, Tantu, Therapeutic Solutions, TLC, Xenon.
BioWorld
Briefs
Other news to note
Coronavirus